Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03040622 · ClinicalTrials.gov registry record
The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial
A clinical trial of Left Atrial Appendage Closure and WATCHMAN Device Implantation, sponsored by Inova Health Care Services.
- Completed
- Registry status
- 35
- Enrollment target
- 1
- Study location
NCT03040622 is a study of Left Atrial Appendage Closure and WATCHMAN Device Implantation that has completed, run by Inova Health Care Services. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03040622, a study of Left Atrial Appendage Closure and WATCHMAN Device Implantation, has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate thrombogenicity in patients undergoing left atrial appendage closure using the WATCHMAN device. Parameters of thrombosis and platelet function, as well as other bio-markers, will be measure before, during, and after WATCHMAN implantation at several follow up visits.
Conditions Studied
Interventions
- DEVICE WATCHMAN Left Atrial Appendage Closure
Study Locations (1)
Virginia
- Inova Fairfax Hospital - Falls Church
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03040622
The ClinicalTrials.gov registry entry for NCT03040622 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Left Atrial Appendage Closure appearing as the primary indexed condition, and to 1 intervention - of which WATCHMAN Left Atrial Appendage Closure is the first listed.
NCT03040622 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03040622 about?
NCT03040622 is a clinical study titled "The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial". This study will evaluate thrombogenicity in patients undergoing left atrial appendage closure using the WATCHMAN device. Parameters of thrombosis and platelet function, as well as other bio-markers, will be measure before, during, and after WATCHMAN implantation at several follow up visits.
What is the current status of trial NCT03040622?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2017-03-01. Estimated completion is 2019-12-31.
What conditions does trial NCT03040622 study?
This clinical trial studies the following conditions: Left Atrial Appendage Closure, WATCHMAN Device Implantation.
What interventions are being tested in trial NCT03040622?
The interventions under investigation include: WATCHMAN Left Atrial Appendage Closure (DEVICE).
Who is sponsoring clinical trial NCT03040622?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03040622 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Left Atrial Appendage Closure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.